Education
About Us
Working with TipRanks
Follow Us
Acura Pharmaceuticals, Inc. (ACUR)
:ACUR
ACUR Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.01 - $0.03
Previous CloseN/A
Volume52.13K
Average Volume (3M)3.13K
Market Cap
$118.80K
Enterprise ValueN/A
Total Cash (Recent Filing)$91.00K
Total Debt (Recent Filing)$4.22M
Price to Earnings (P/E)―
Beta1.57
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding66,001,785
10 Day Avg. Volume5,543
30 Day Avg. Volume3,128
Standard Deviation13.08
R-Squared0.04
Alpha1.72
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.05
Price to Cash Flow (P/CF)0.20
P/FCF Ratio0.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Acura Pharmaceuticals News
PremiumCompany Announcements
Acura Pharmaceuticals Announces Executive Leadership Transition
PremiumCompany Announcements
Acura Pharmaceuticals Secures Loan, Faces Bankruptcy Risk---
Ownership Overview
5.49%
Insiders
<0.01% Other Institutional Investors
94.51% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
ACUR FAQ
What was Acura Pharmaceuticals, Inc.’s price range in the past 12 months?
Acura Pharmaceuticals, Inc. lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
What is Acura Pharmaceuticals, Inc.’s market cap?
Acura Pharmaceuticals, Inc.’s market cap is $118.80K.
When is Acura Pharmaceuticals, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Acura Pharmaceuticals, Inc.’s earnings last quarter?
Currently, no data Available
Is Acura Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Acura Pharmaceuticals, Inc.’s price is currently Overvalued.
Does Acura Pharmaceuticals, Inc. pay dividends?
Acura Pharmaceuticals, Inc. does not currently pay dividends.
What is Acura Pharmaceuticals, Inc.’s EPS estimate?
Acura Pharmaceuticals, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Acura Pharmaceuticals, Inc. have?
Acura Pharmaceuticals, Inc. has 66,001,785 shares outstanding.
What happened to Acura Pharmaceuticals, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Acura Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in ACUR
---
Company Description
Acura Pharmaceuticals, Inc.
Acura Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the research, development, and commercialization of abuse deterrent, orally administered pharmaceutical products. Its technology platforms include AVERSION, IMPEDE, and LIMITX. The company was founded on April 10, 1935 and is headquartered in Palatine, IL.
---
ACUR Stock 12 Month Forecast
Average Price Target
―---